Lighthouse shines awareness on patient enrollment barriers. We integrate patient internet use, focused webinars, awareness data mining and AI, with “Boots on the Ground” global field scientists, guiding patients and healthcare professionals to targeted clinical trials, connecting the right patient to the right trial on time. Lighthouse is a services organization by Celerity Biosciences. The company formed in 2017 based on the team that helped drive medical affairs and market readiness for the STARTRK-2 trial (entrectinib) in 15 countries, testing for TRK and ROS1 rare disease patients.